Woiwode Thomas
- SEC CIK
- 0001619294
No open-market purchases or sales filed in the past year.
Current role at each company
- PASG Passage BIO, Inc.Director, 10% Owneras of May 26, 2023
- ALGS Aligos Therapeutics, Inc.Directoras of Jun 27, 2022
- TPST Tempest Therapeutics, Inc.Directoras of Jun 22, 2022
- GRTS Gritstone bio, Inc.Directoras of Aug 27, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Woiwode Thomas as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TPST Tempest Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 3, 2022 (view filing) | Apr 29 | 4 days | Woiwode ThomasDirector, 10% Owner | PPurchase | +2.12M | $2.36 | +$5.00M | New position2.12M after |